vs
Side-by-side financial comparison of AbbVie (ABBV) and National Vision Holdings, Inc. (EYE). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($16.6B vs $487.3M, roughly 34.1× National Vision Holdings, Inc.). AbbVie runs the higher net margin — 10.9% vs 0.7%, a 10.2% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (10.0% vs 7.9%). AbbVie produced more free cash flow last quarter ($4.9B vs $30.3M). Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs 7.6%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.
ABBV vs EYE — Head-to-Head
Income Statement — Q4 2025 vs Q3 2026
| Metric | | |
|---|---|---|
| Revenue | $16.6B | $487.3M |
| Net Profit | $1.8B | $3.4M |
| Gross Margin | 72.6% | — |
| Operating Margin | 27.3% | 2.0% |
| Net Margin | 10.9% | 0.7% |
| Revenue YoY | 10.0% | 7.9% |
| Net Profit YoY | 8354.5% | 139.8% |
| EPS (diluted) | $1.02 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.6B | — | ||
| Q3 25 | $15.8B | $487.3M | ||
| Q2 25 | $15.4B | $486.4M | ||
| Q1 25 | $13.3B | $510.3M | ||
| Q4 24 | $15.1B | $437.3M | ||
| Q3 24 | $14.5B | $451.5M | ||
| Q2 24 | $14.5B | $451.7M | ||
| Q1 24 | $12.3B | $482.8M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $186.0M | $3.4M | ||
| Q2 25 | $938.0M | $8.7M | ||
| Q1 25 | $1.3B | $14.2M | ||
| Q4 24 | $-22.0M | $-28.6M | ||
| Q3 24 | $1.6B | $-8.5M | ||
| Q2 24 | $1.4B | $-3.1M | ||
| Q1 24 | $1.4B | $11.7M |
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 66.7% | — |
| Q4 25 | 27.3% | — | ||
| Q3 25 | 12.1% | 2.0% | ||
| Q2 25 | 31.7% | 3.4% | ||
| Q1 25 | 28.0% | 5.1% | ||
| Q4 24 | -9.9% | -5.8% | ||
| Q3 24 | 26.5% | -2.0% | ||
| Q2 24 | 27.6% | 0.1% | ||
| Q1 24 | 22.7% | 4.9% |
| Q4 25 | 10.9% | — | ||
| Q3 25 | 1.2% | 0.7% | ||
| Q2 25 | 6.1% | 1.8% | ||
| Q1 25 | 9.6% | 2.8% | ||
| Q4 24 | -0.1% | -6.5% | ||
| Q3 24 | 10.8% | -1.9% | ||
| Q2 24 | 9.5% | -0.7% | ||
| Q1 24 | 11.1% | 2.4% |
| Q4 25 | $1.02 | — | ||
| Q3 25 | $0.10 | $0.04 | ||
| Q2 25 | $0.52 | $0.11 | ||
| Q1 25 | $0.72 | $0.18 | ||
| Q4 24 | $-0.03 | $-0.36 | ||
| Q3 24 | $0.88 | $-0.11 | ||
| Q2 24 | $0.77 | $-0.04 | ||
| Q1 24 | $0.77 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.3B | $56.0M |
| Total DebtLower is stronger | $58.9B | $236.5M |
| Stockholders' EquityBook value | $-3.3B | $858.8M |
| Total Assets | $134.0B | $2.0B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.7B | $56.0M | ||
| Q2 25 | $6.5B | $48.5M | ||
| Q1 25 | $5.2B | $80.0M | ||
| Q4 24 | $5.6B | $73.9M | ||
| Q3 24 | $7.3B | $81.2M | ||
| Q2 24 | $13.2B | $179.5M | ||
| Q1 24 | $18.1B | $150.1M |
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | $236.5M | ||
| Q2 25 | $63.0B | $255.6M | ||
| Q1 25 | $64.5B | $244.7M | ||
| Q4 24 | $60.3B | $248.6M | ||
| Q3 24 | $58.5B | $252.8M | ||
| Q2 24 | $58.0B | $143.9M | ||
| Q1 24 | $63.8B | $448.6M |
| Q4 25 | $-3.3B | — | ||
| Q3 25 | $-2.6B | $858.8M | ||
| Q2 25 | $-183.0M | $850.6M | ||
| Q1 25 | $1.4B | $836.2M | ||
| Q4 24 | $3.3B | $816.3M | ||
| Q3 24 | $6.0B | $840.0M | ||
| Q2 24 | $6.8B | $843.4M | ||
| Q1 24 | $8.0B | $841.3M |
| Q4 25 | $134.0B | — | ||
| Q3 25 | $133.9B | $2.0B | ||
| Q2 25 | $137.2B | $2.0B | ||
| Q1 25 | $136.2B | $2.0B | ||
| Q4 24 | $135.2B | $2.0B | ||
| Q3 24 | $143.4B | $2.0B | ||
| Q2 24 | $141.9B | $2.1B | ||
| Q1 24 | $148.9B | $2.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | 45.44× | 0.29× | ||
| Q4 24 | 18.15× | 0.30× | ||
| Q3 24 | 9.70× | 0.30× | ||
| Q2 24 | 8.56× | 0.17× | ||
| Q1 24 | 7.97× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.2B | $46.6M |
| Free Cash FlowOCF − Capex | $4.9B | $30.3M |
| FCF MarginFCF / Revenue | 29.4% | 6.2% |
| Capex IntensityCapex / Revenue | 2.0% | 3.4% |
| Cash ConversionOCF / Net Profit | 2.87× | 13.83× |
| TTM Free Cash FlowTrailing 4 quarters | $17.8B | $83.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.2B | — | ||
| Q3 25 | $7.0B | $46.6M | ||
| Q2 25 | $5.2B | $54.3M | ||
| Q1 25 | $1.6B | $32.2M | ||
| Q4 24 | $7.0B | $30.3M | ||
| Q3 24 | $5.4B | $27.9M | ||
| Q2 24 | $2.3B | $51.5M | ||
| Q1 24 | $4.0B | $24.0M |
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | $30.3M | ||
| Q2 25 | $4.9B | $42.4M | ||
| Q1 25 | $1.4B | $12.0M | ||
| Q4 24 | $6.8B | $-1.7M | ||
| Q3 24 | $5.2B | $4.1M | ||
| Q2 24 | $2.0B | $31.9M | ||
| Q1 24 | $3.8B | $4.0M |
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | 6.2% | ||
| Q2 25 | 31.7% | 8.7% | ||
| Q1 25 | 10.5% | 2.4% | ||
| Q4 24 | 44.7% | -0.4% | ||
| Q3 24 | 35.9% | 0.9% | ||
| Q2 24 | 14.0% | 7.1% | ||
| Q1 24 | 31.3% | 0.8% |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | 3.4% | ||
| Q2 25 | 1.7% | 2.4% | ||
| Q1 25 | 1.8% | 4.0% | ||
| Q4 24 | 1.9% | 7.3% | ||
| Q3 24 | 1.7% | 5.3% | ||
| Q2 24 | 1.7% | 4.3% | ||
| Q1 24 | 1.6% | 4.1% |
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | 13.83× | ||
| Q2 25 | 5.49× | 6.22× | ||
| Q1 25 | 1.27× | 2.27× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | 2.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
